News
2d
Axios on MSNFDA panel backs menopausal hormone therapyAn Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...
2d
Flow Space on MSNFDA Experts Call for Rethink on Menopause Hormone Therapy WarningsOn Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...
The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...
2d
MedPage Today on MSNRemove Boxed Warning on Hormone Therapy for Menopause, FDA Panel SaysA panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...
“The role of testosterone is just a lesson in gender bias,” says Kelly Casperson, MD, a urologist. “Because 100 percent of ...
Overall, this suggests that the cumulative risk of breast cancer before age 55 for women taking estrogen/progestin is about 4 ...
Puerto Rican Gov. Jennifer Gonzalez signed a bill into law that bans hormone therapy and gender-affirming surgeries for ...
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...
A transgender woman incarcerated in Eastern Kentucky is suing the state's prison system over a plan to cut off her ...
Hormone therapy can be used to boost hormone levels and relieve menopause symptoms, which typically last an average of five years but can be as long as 10 years.
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results